The oxidative neurotoxicity of clioquinol

Neuropharmacology

Volumn 49, Issue 5, 2005, Pages 687-694

  Benvenisti Zarom, Luna ^a   Chen, Jing ^a   Regan, Raymond F ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Amyloid; Alzheimer's disease; Chelator; Free radical; Iron; Oxidative

Indexed keywords

1,10 PHENANTHROLINE; ANTIOXIDANT; ASCORBIC ACID; CHELATING AGENT; CLIOQUINOL; CYANOCOBALAMIN; HEME OXYGENASE 2; MALONALDEHYDE; TROLOX C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL DEATH; CELL PROTECTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; MOUSE; NERVE CELL; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TISSUE CULTURE; TOXICITY TESTING;

ANIMALS; ANTIOXIDANTS; CELL DEATH; CELLS, CULTURED; CHELATING AGENTS; CLIOQUINOL; HEME OXYGENASE (DECYCLIZING); HEMOGLOBINS; L-LACTATE DEHYDROGENASE; MALONDIALDEHYDE; MICE; MICE, KNOCKOUT; MICROSCOPY, PHASE-CONTRAST; NEURONS; OXIDANTS; OXIDATIVE STRESS; PHENANTHROLINES; VITAMIN B 12;

EID: 23944513020     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2005.04.023     Document Type: Article

References (37)

1. H. Atamna, and W.H. Frey 2nd A role for heme in Alzheimer's disease: heme binds amyloid beta and has altered metabolism Proc. Natl. Acad. Sci. USA 101 2004 11153 11158
2. R.A. Cherny, C.S. Atwood, M.E. Xilinas, D.N. Gray, W.D. Jones, C.A. McLean, K.J. Barnham, I. Volitakis, F.W. Fraser, Y. Kim, X. Huang, L.E. Goldstein, R.D. Moir, J.T. Lim, K. Beyreuther, H. Zheng, R.E. Tanzi, C.L. Masters, and A.I. Bush Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice Neuron 30 2001 665 676
3. R.A. Cherny, J.T. Legg, C.A. McLean, D.P. Fairlie, X. Huang, C.S. Atwood, K. Beyreuther, R.E. Tanzi, C.L. Masters, and A.I. Bush Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion J. Biol. Chem. 274 1999 23223 23228
4. M.P. Cuajungco, and G.J. Lees Zinc metabolism in the brain: relevance to human neurodegenerative disorders Neurobiol. Dis. 4 1997 137 169
5. J.M.C. Gutteridge Iron and oxygen radicals in the brain Ann. Neurol. 32 1992 S16 S21
6. B.J. Gwag, D. Lobner, J.Y. Koh, M.B. Wie, and D.W. Choi Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro Neuroscience 68 1995 615 619
7. B. Halliwell, and J.M.C. Gutteridge Free Radicals in Biology and Medicine 1999 Oxford University Press Oxford
8. R.C. Hilder Design of therapeutic chelating agents Biochem. Soc. Trans. 30 2002 751 754
9. F.P. Huang, G. Xi, R.F. Keep, Y. Hua, A. Nemoianu, and J.T. Hoff Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products J. Neurosurg. 96 2002 287 293
10. D. Kaur, F. Yantiri, S. Rajagopalan, J. Kumar, J.Q. Mo, R. Boonplueang, V. Viswanath, R. Jacobs, L. Yang, M.F. Beal, D. DiMonte, I. Volitaskis, L. Ellerby, R.A. Cherny, A.I. Bush, and J.K. Andersen Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease Neuron 37 2003 899 909
11. J.Y. Koh, and D.W. Choi Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay J. Neurosci. Methods 20 1987 83 90
12. M. Konagaya, A. Matsumoto, S. Takase, T. Mizutani, G. Sobue, T. Konishi, T. Hayabara, H. Iwashita, T. Ujihira, K. Miyata, and Y. Matsuoka Clinical analysis of longstanding subacute myelo-optico-neuropathy: sequelae of clioquinol at 32 years after its ban J. Neurol. Sci. 218 2004 85 90
13. H. Kotaki, S. Hori, Y. Saitoh, F. Nakagawa, and Z. Tamura Absorption, distribution and metabolism of clioquinol in clioquinol-sensitive and -resistant neonatal rats J. Pharmacobiodyn. 9 1986 970 974
14. J.P. Kushner, J.P. Porter, and N.F. Olivieri Secondary iron overload Hematology 2001 2001 47 61
15. 2+)-ATPase by nonheme iron Biochim. Biophys. Acta 1062 1991 35 38
16. 2+)-ATPase by hemin Biochim. Biophys. Acta 946 1988 49 56
17. Y. Matsuki, T. Ito, K. Fukuhara, M. Abe, T. Othaki, and T. Nambara Determination of chinoform in biological fluids and nervous tissues of the dog by gas chromatography-mass spectrometry Arch. Toxicol. 59 1987 374 378
18. I. Mavelli, A. Rigo, R. Federico, M.R. Ciriolo, and G. Rotilio Superoxide dismutase, glutathione peroxidase and catalase in developing rat brain Biochem. J. 204 1982 535 540
19. T.Q. Nijst, R.A. Wevers, H.C. Schoonderwaldt, O.R. Hommes, and A.F. de Haan Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia J. Neurol. Neurosurg. Psychiatry 53 1990 951 954
20. F. Petrat, H. de Groot, and U. Rauen Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells Biochem. J. 356 2001 61 69
21. S.P. Raps, J.C.K. Lai, L. Hertz, and A.J.L. Cooper Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons Brain Res. 493 1989 398 401
22. R.F. Regan, J. Chen, and L. Benvenisti-Zarom Heme oxygenase-2 gene deletion attenuates oxidative stress in neurons exposed to extracellular hemin BMC Neurosci. 5 2004 34
23. R.F. Regan, and D.W. Choi The effect of NMDA, AMPA/kainate, and calcium channel antagonists on traumatic cortical neuronal injury in culture Brain Res. 633 1994 236 242
24. R.F. Regan, E. Jasper, Y.P. Guo, and S.S. Panter The effect of magnesium on oxidative neuronal injury in vitro J. Neurochem. 70 1998 77 85
25. B. Regland, W. Lehmann, I. Abedini, K. Blennow, M. Jonsson, I. Karlsson, M. Sjogren, A. Wallin, M. Xilinas, and C.G. Gottfries Treatment of Alzheimer's disease with clioquinol Dement. Geriatr. Cogn. Disord. 12 2001 408 414
26. J.R. Ricoy, A. Ortega, and A. Cabello Subacute myelo-optic neuropathy (SMON). First neuro-pathological report outside Japan J. Neurol. Sci. 53 1982 241 251
27. C.W. Ritchie, A.I. Bush, A. Mackinnon, S. Macfarlane, M. Mastwyk, L. MacGregor, L. Kiers, R. Cherny, Q.X. Li, A. Tammer, D. Carrington, C. Mavros, I. Volitakis, M. Xilinas, D. Ames, S. Davis, K. Beyreuther, R.E. Tanzi, and C.L. Masters Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial Arch. Neurol. 60 2003 1685 1691
28. B. Rogers, V. Yakopson, Z.P. Teng, Y. Guo, and R.F. Regan Heme oxygenase-2 knockout neurons are less vulnerable to hemoglobin toxicity Free Rad. Biol. Med. 35 2003 872 881
29. J. Rosenfeld, A.W. Zimmerman, and V.L. Friedrich Jr. Altered brain copper and zinc content in quaking mice Exp. Neurol. 82 1983 55 63
30. L.P. Rowland Nutritional disorders: vitamin B12 deficiency, malabsorption, and malnutrition L.P. Rowland Merritt's Textbook of Neurology 1995 Williams & Wilkins Baltimore 945 948
31. H. Shiraki The neuropathology of subacute myelo-optico-neuropathy, "SMON", in the humans - with special reference to the quinoform intoxication Jpn. J. Med. Sci. Biol. 28 Suppl 1975 101 164
32. H. Taguchi, H. Sanada, K. Hara, I. Miyoshi, and K. Hiraki Vitamin B12 levels of cerebrospinal fluid in patients with a variety of neurological disorders J. Nutr. Sci. Vitaminol. (Tokyo) 23 1977 299 304
33. J. Tateishi Subacute myelo-optico-neuropathy: clioquinol intoxication in humans and animals Neuropathology 20 2000 S20 S24
34. B.M. Todorich, and J.R. Connor Redox metals in Alzheimer's disease Ann. N.Y. Acad. Sci. 1012 2004 171 178
35. Y. Toyokura, and T. Takasu Clinical features of SMON Jpn. J. Med. Sci. Biol. 28 1975 87 99
36. K. Yagi, K. Ohtsuka, and N. Ohishi Lipid peroxidation caused by chinoform-ferric chelate in cultured neural retinal cells Experientia 41 1985 1561 1563
37. M.S. Yassin, J. Ekblom, M. Xilinas, C.G. Gottfries, and L. Oreland Changes in uptake of vitamin B(12) and trace metals in brains of mice treated with clioquinol J. Neurol. Sci. 173 2000 40 44